Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04707651 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04707651 · ClinicalTrials.gov record · last posted 2026-06-04

Formula Diet Treatment for NASH Patients.

Study acronym: NASH
StatusActive, Not Recruiting
PhaseNot applicable
Started2021-01-18
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2021-01-11; most recent amendment 2026-06-02. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-07-10
Status change Recruiting→Active, Not Recruitingv4
2021-04-12
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT04707651
Lead Sponsor West German Center of Diabetes and Health
Conditions Steatohepatitis, Nonalcoholic
Enrollment 20 participants
Start Date 2021-01-18
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-04